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This short review provides an overview of the impact micro- and nanotechnologies
can make in studying epigenetic structures. The importance of mapping histone
modifications on chromatin prompts us to highlight the complexities and challenges
associated with histone mapping, as compared to DNA sequencing. First, the
histone code comprised over 30 variations, compared to 4 nucleotides for DNA.
Second, whereas DNA can be amplified using polymerase chain reaction, chromatin
cannot be amplified, creating challenges in obtaining sufficient material for analysis.
Third, while every person has only a single genome, there exist multiple
epigenomes in cells of different types and origins. Finally, we summarize existing
technologies for performing these types of analyses. Although there are still
relatively few examples of micro- and nanofluidic technologies for chromatin
analysis, the unique advantages of using such technologies to address inherent
challenges in epigenetic studies, such as limited sample material, complex readouts,
and the need for high-content screens, make this an area of significant growth and
opportunity.VC 2013 AIP Publishing LLC. [http://dx.doi.org/10.1063/1.4816835]
I. INTRODUCTION
The biological “instruction manual” for structure, function, and growth has long been con-
sidered to be encoded in the DNA of organisms. Interactions between DNA and external factors
drive differential transcription of these genes into proteins, producing transmittable signals that
regulate function. However, cells can present distinct heritable phenotypes, without changes in
the underlying DNA. Alterations to the instruction manual via these “epigenetic” changes, such
as DNA methylation or histone modifications, have recently generated tremendous scientific in-
terest.1 As these changes are transmitted from parent to child, the existence of epigenetic mech-
anisms suggest that lifestyle choices may impact future generations.2–7 Conversely, epigenetic
mechanisms may enable us to manipulate or avoid the conditions that drive phenotypic expres-
sion of a genetic disorder. Hence, with implications in cancer,8–10 autism,11,12 and Alzheimer’s
disease,13,14 the epigenetic paradigm provides a powerful set of tools with which to understand
the transmission and etiology of diseases, and ultimately design treatments for genetic disorders
that need not rely on potentially hazardous genetic modification.15
Epigenetics also have significant implications in the fields of tissue engineering,16 regenera-
tive medicine,17,18 and creating artificial in vitro cell culture models;19 particularly in sourcing
cells for these technologies. A particularly promising approach is the use of embryonic, adult,
and induced pluripotent stem cells,20 which can be differentiated towards a specified phenotype.21
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This powerful technique enables basic scientists and clinicians to create autologous artificial tis-
sues for transplantation,22 or to better study various aspects of disease using genetically identical
source materials; but the epigenetic paradigm raises a significant concerns about this process.23
Differentiated cells may contain significant and previously unsuspected epigenetic variations
(Fig. 1), arising from the use of chemical differentiation reagents24 and from requirements to pre-
pare undifferentiated stem cells for long periods in culture.25 These epigenetic differences may
lead to unexpected and potentially detrimental cell functionality, such as uncontrolled cancerous
proliferation.23–25 Hence, techniques to rapidly assess the epigenetic profiles of differentiated and
diseased cells are of critical importance in a broad variety of applications.
The most commonly used method for chromatin analysis is the chromatin immunopreci-
pitation (ChIP) assay.26 In this technique, chromatin (the contents of the cell nucleus, includ-
ing DNA and associated proteins) protein, and DNA are temporarily bonded together and the
chromatin is chopped up by mechanical shear into multiple small DNA-protein fragments.
Select fragments containing proteins of interest are then precipitated from the solution using
bead-attached antibodies. Proteins are then removed from the collected fragments and the
DNA is purified and sequenced. The result is a list of short DNA fragments that had been
bound by a specific protein of interest. While ChIP is very useful, the technique can analyze
only one histone modification at a time. With over 30 different types of histone modifications
known,28 the amount of time, money, and cellular material required to do a thorough map-
ping is prohibitive (Table I). Alternative technologies to current ChIP techniques are
required.
In this review, we provide an overview of the importance and need for analysis of epige-
netic markers on chromatin in eukaryotes. We then review technologies aimed at improving
chromatin mapping capabilities particularly in terms of using fewer cells and less starting
material. For the technology part of this review, we first focus on microfluidic methods that
aim to improve upon ChIP (2nd generation epigenetic analysis tools), then describe nanoflui-
dic, non-ChIP technologies (3rd generation epigenetic analysis tools) to perform chromatin
mapping.
FIG. 1. The concept of epigenetic regulation and reprogramming. Fertilized egg represents totipotency or iPS and ES repre-
sents pluripotency, they have the potential to differentiate down all pathways through dynamic epigenetic regulation.
Bottom roots represent differentiated cells such as skin, neurons, liver, lung, muscle, blood cells, etc. Alternatively, differ-
entiated cell types in an individual can reverse their fate through epigenetic reprogramming. These induced pluripotent cells
can be re-differentiated to various cell types through dynamic epigenetic regulation, but cannot develop into an individual.
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II. CHALLENGES IN CHROMATIN ANALYSIS
A. Chromatin structure influences cell function
DNA in a living cell must be accessible so as to readily perform vital biological functions
such as gene transcription, DNA replication, DNA recombination, and DNA repair. At the
same time, however, the meter-long eukaryotic DNA must be highly condensed so as to fit into
the nucleus, which affords space of only a few microns in size. The two seemingly incompati-
ble requirements of extremely compact storage and rapid accessibility have prompted a decade
of intense studies of chromatin organization. The hierarchical structure of chromatin necessary
to achieve this degree of packing and accessibility of DNA has subtle and diverse features at
all levels of organization, some of which have only recently been understood.27 Since the struc-
ture of chromatin itself likely regulates aspects of gene transcription,28 understanding these fac-
tors is of critical importance in probing epigenetics. Intensive research has been conducted to
characterize the structural and functional properties of chromatin using diverse experimental
and modeling techniques including atomic force microscopy (AFM),29–31 optical/magnetic
tweezers,32,33 electron microscopy,34,35 and X-ray scattering methods.36,37
DNA is coiled around a nucleosome core comprising four pairs of histone proteins, and
nucleosomes are connected to each other by linker DNA (often represented by a “beads-on-a-
string” model) (Fig. 2(a)).38 However, the higher-order structure that the primary chromatin
strand coils into is still actively debated.35 A regularly arranged secondary structure known as
the “30 nm fiber” is believed to exist.34,35,39 The organization of this fiber is achieved through
two major structures: the “one-start” or solenoid model, in which two successive nucleosomes
follow a helical path and are connected by bent linker DNA; or the “two-start” or zig-zag
model, in which nucleosomes directly interact with each other with minimal bending of linker
DNA between them (Fig. 2(b)).40 In vitro and modeling studies provide considerable evidence
that this secondary structure is strongly dependent on various properties such as the length of
linker DNA, the existence and properties of linker histones, and experimental conditions such
as ion valence and concentration (see references reviewed in Ref. 40). At physiological ion con-
centrations, the secondary chromatin contains uneven proportions of both type of structures
(“heteromorphic fibers”).35,38 Furthermore, more recent evidence suggests that even the regular
30-nm fiber structure does not exist consistently in living mammalian cells.37,41,42 Hence, our
TABLE I. Comparison for methods of conventional ChIP, improved ChIP, and ChIP in micro/nanofluidics.
Operation
time
Starting
number
of cells
No. of target
antibodies
(reaction spots)
No. of
genomic
sites Ref.
Conventional ChIP Several days 106–107 cells One Many 27
Improved ChIP methods
Carrier ChIP 2–3 days 100 cells One One 67
Fast ChIP 5 ha 106–107 cells 24 Several 68
Quick and quantitative ChIP A day 105 cells 100–1000 One 69
Matrix ChIP 4–5 ha 106 cells/well 96 (ideal) One/well 70
Micro ChIP A day 100–1000 cells 1–16 Few 71
8 ha Biopsy (1 mm3) 16 One 72
ChIP in micro/nanofluidics
DNA-enrichment microfluid ChIP 2–3 hb 2.5 106 cells One Several 73
Automated microfluidic ChIP A day 8000 cells 4 Several 74
High-throughput automated ChIP A day 104 cells 16 Several 75
Microfluidic ChIP 8.5 hb 50 cells One Several 76
aExcept PCR time.
bExcept DNA purification and PCR time.
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current understanding of chromatin structure suggests that the chromatin in a cell exists in a
melt-like dynamic state, providing greater accessibility for biological purposes than the conven-
tional static model.41 Also on a primary structural level, there are small variations in amino-
acid sequences even though core histones are highly conserved proteins across species. The
variations can influence the stability and dynamic state of the primary structure, thereby influ-
encing the rate and duration of gene activation. Taken together, the variability, irregularity, and
dynamics in the hierarchy of chromatin structures represent an epigenetic mechanism, as they
form based on specific needs and conditions in a given biological environment. Simply mapping
end-point protein-DNA interactions using ChIP assays are unable to recreate and capture these
dynamic complexities.
Computational models have greatly enhanced our understanding of the structure of chroma-
tin. In most studies of chromatin structure, only the essential elements of the system are
retained to reduce the degrees of freedom in the model.40 In the most basic course-grain (CG)
models, chromatin is modeled as a linear string of nucleosomes connected by linker DNA
(“beads-on-a-string”) (Fig. 2(c)).43 The nucleosomes can then be modeled as cylindrical objects
to which two torsional springs are attached. The angle between the two (entry/exit) springs at a
nucleosome and the torsional angle in each spring are the variables in the dynamics of the CG
model. The interactions between nucleosomes can be modeled by using an “effective potential”
FIG. 2. Schematic of DNA folding in the cell and higher coarse-grained models of chromatin. (a) Bare DNA is folded to
form highly condensed chromatin structures such as a chromosome. The structure of compact chromatin is still uncertain
but a compact chromatin fiber is a likely candidate. Reprinted with permission from Schlick et al., J. Biol. Chem. 287,
5183 (2012). Copyright 2012 American Society for Biochemistry and Molecular Biology. (b) A chromatin fiber model can
be defined by the opening angle between the incoming and outgoing linker DNA of length l, torsional angle of the linker
DNA, and the interactions between nucleosomes and linker DNA. Reprinted with permission from Aumann et al., Phys.
Rev. E 73, 041927 (2006). Copyright 2006 American Physical Society. (c) A heteromorphic-chromatin stretching simula-
tion where the components such as linker histone and the nucleosome surface charge distribution are explicitly modeled.
Reprinted with permission from Schlick et al., J. Biol. Chem. 287, 5183 (2012). Copyright 2012 American Society for
Biochemistry and Molecular Biology.
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term that accounts for all the interactions among the simplified neighboring elements such as
surface charges, ions, and solvent interactions. Even this simple model provides insights into
how the global bending and stretching stiffness depend on the chromatin primary structure.40
Recently, the Schlick group43 has developed a more refined CG model that explicitly includes
realistic geometric shapes of the nucleosome, histone tails, linker histone, and ion valence/
concentration dependence, using a Debye-H€uckel model. The model can quantitatively repro-
duce the force vs. extension curve in various regimes and predict the structural role of the chro-
matin components in higher-order compaction and organization of chromatin.43 Furthermore, as
demonstrated by Yang et al.,44 explicit modeling of the ion and charge distribution in multi-
valence/high concentration polyelectrolytes (such as in the case of salt-induced chromatin
aggregation; Fig 2(c)) is necessary to adequately capture model dynamics.43 The CG model of
higher-order chromatin structures in solution has matured enough to complement experimental
results.27
B. Broad variety of histone modifications
A key structural unit of chromatin is the nucleosome. Nucleosomes in eukaryotes consist
of DNA coiled around an octamer core comprised four types of histone proteins: H2A, H2B,
H3, and H4, each of which has a high affinity for DNA. Nucleosomes are bound at the entry
and exit sites of the DNA by the linker histone H1.45–47 About 147 base-pairs of DNA are
tightly wound around a histone octamer. The terminal regions of these histones are exposed to
modifications, such as acetylation and methylation that can dynamically change chromatin
structure, regulating accessibility of proteins to the DNA.48 For example, activity of transcrip-
tion factors can be blocked or enhanced based on modification of the histone. This mechanism
makes it physically possible to regulate gene expression independently from the DNA sequence,
creating an epigenetic effect (Fig. 3(a)).49
The variety of known histone modifications is large and growing. The most extensively
documented modifications include acetylation, methylation, phosphorylation, ubiquitination, and
biotinylation.50 In particular, acetylation on histone H4 and methylation of lysine 9 on histone
H3 can significantly influence chromatin structure of euchromatin (decondensed chromatin) and
heterochromatin (highly condensed chromatin), respectively.51–54 Hence, patterns of these his-
tone modifications, collectively referred to as the “histone code” can physically regulate gene
expression and transcription.55 Currently, researchers commonly consider 24 histone modifica-
tions of acetylation and methylation on 22 modification sites (Fig. 3). Modifications are quickly
being added to this list to include ubiquitination,56,57 adenosine diphosphate (ADP)-ribosyla-
tion,58,59 citrullination,60 and sumoylation.61 Analysis of each of these modifications requires
the development and validation of uniquely specific antibodies. As ChIP analysis is typically
limited to precipitation of protein-DNA fragments using a single antibody at a time, histone
FIG. 3. Transcriptional relationship between chromatin structure and epigenetic modifications on histones. Gene transcrip-
tional activity can be controlled by chromatin structure such as heterochromatin and euchromatin. These chromatin struc-
tures can also be controlled by histone modifications, as demonstrated in the diagram which shows post-translational
histone modifications on each histone (Ac, acetylation; Me, Methylation).
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mapping of the epigenetic state grows more complex and time consuming with the discovery of
each new modification. Given the quantity of potential modifications, and the rate of discovery
of new modifications, new methods to study these modifications and their effects on chromatin
structure are important to develop.
C. One genome but many epigenomes per person
Generally, the genomic DNA sequence of cells within an individual person is all the same.
The human genome project, successfully achieved over 10 years ago and progressively
improved upon, enables an individual person’s DNA to be mapped for less than $1000, from
amplification of genetic contents of a single cell.62 While knowledge of the complete genomic
sequence is useful to detect genomic variations such as single-nucleotide polymorphism analy-
sis, this information is not always sufficient to understand individual cell type-based function
and phenotype. To understand cell type-dependent functional differences, not only the DNA
sequence but also knowledge of how that DNA is packaged within the cell’s nucleus is
required. In other words, epigenomic information of that specific cell that includes patterns of
histone modifications across the whole genome is needed.63 This is because significant epige-
nomic diversity exists not only between individuals in a population but also from tissue to tis-
sue, and between individual cells within the same tissue.9,64
Unfortunately, no technology currently exists with which to study the epigenetic profile of
chromatin from a single cell. DNA amplification cannot be utilized, as it does not replicate the
modified histones and structure of the chromatin necessary for epigenetic analysis. Recently,
the Encyclopedia of DNA Elements (ENCODE) project undertook a massive research program
involving the compilation of many researchers’ efforts in mapping the epigenome.65 However,
even this well-funded consortium chose to study cell lines, at least in part, due to the need to
produce sufficient numbers of cells for the epigenetic analyses such as ChIP. The ability to
map histone states using chromatin from a single cell would greatly reduce the time and cost
involved in such endeavors. Additionally, the ability to perform histone mapping of single cells
would open new opportunities in understanding cell-to-cell variability of the epigenome as well
as in identifying and understanding rare cells, such as cancer progenitors or pluripotent stem
cells, which play critical roles in disease and repair but are currently very difficult to analyze
due to lack of starting cellular materials.
III. MICRO- AND NANOFLUIDIC APPROACHES
Conventional methods to study chromatin are limited in their ability to provide sufficient
information at a single cell level—information critical for rare cell or cell differentiation
research.26,66–71 These issues are compounded by the complexity and insufficient-throughput of
such technologies given the challenges associated with having over 30 histone modification pos-
sibilities and multiple epigenomes per person. Recent advancements in micro/nanotechnology
offer opportunities for the study of chromatin at the single cell level using mechanisms that
allow for precise control, improved handling, and higher throughput studies. In this section, cur-
rent studies related to chromatin in micro/nanofluidics platforms as well as potential future
applications will be discussed. We divide this section into two parts: part one consists of meth-
ods that aim to improve upon ChIP and are mainly microfluidic, and the second part focuses on
non-ChIP methods comprised 3rd generation nanofluidic systems.
A. ChIP in micro/nanofluidics
ChIP has been exploited to study DNA-protein interactions and histone modifications for
many years. Despite the capabilities and history of this technology, ChIP assays can be chal-
lenging to perform. It requires several sequential steps: (1) cell lysis, (2) binding of an antibody
to a target DNA-binding protein, (3) immunoprecipitation of the antibody and antigen complex
using a secondary antibody and beads, (4) purification, and (5) further analysis such as poly-
merase chain reaction (PCR) and sequencing. Multiple processing steps in any assay typically
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results in larger sample requirements and assay time. In contrast to conventional technologies,
miniaturized micro/nanofluidics platforms require only small amount of sample volume, can
simplify and accelerate the assay, and enables the study of single cells in a high-throughput
manner.
Microfluidic systems can greatly improve antibody reaction and immunoprecipitation times
in ChIP assays. Lee et al. utilize microfluidics to demonstrate an efficient approach for ChIP
assays (Fig. 4(a)).72 The microfluidic polydimethylsiloxane (PDMS) chip is separated into four
parts; an inlet, a bead reservoir, three dispersion channels, and an outlet. A cell suspension,
containing fragmented chromatin sheared by sonication, is introduced by a peristaltic pump.
The solution is dragged into the microbeads reservoir where target protein/DNA is captured by
antibody-coated microbeads. The rest of the solution flows to an outlet through a small dam
interface between the bead reservoir and dispersion channels. After a washing step to remove
non-specific binding molecules, the histone/DNA molecules bound to the microbeads are
extracted and the DNA molecules are isolated. Further DNA analysis is performed by PCR.
Optimized dispersion and DNA shearing conditions for efficient immunoprecipitation are
identified based on computational fluid dynamic (CFD) modeling. This filtration design allows
simultaneous concentration and precipitation of target chromatin, resulting in small sample
requirements, shorter operation time, and skill-independent work. They utilized the technology
to rapidly purify a target gene, GAPDH, in a human cell line. As a result, experimental effi-
ciency was verified in comparison to a commercial ChIP assay kit (Table I).
Microfluidics can also be used to improve assay throughput and automation. Quake and
coworkers designed an automated microfluidic platform for ChIP that requires small cell popu-
lations (Fig. 4(b)).73 Fluid flow within the microfluidic chip was controlled using integrated
pneumatic valves and pumps, enabling rapid and automated processing of immunoprecipitation
procedures. More specifically, mixtures of fixed cells and microbeads are loaded in ring 1, and
then sequential buffer solutions are applied to create a cell lysate; NP40 buffer increases cell
permeability, micrococcal nuclease (MNase) breaks chromatin into several DNA fragments, and
FIG. 4. Micro/nanofluidic technologies for ChIP assays. (a) Schematic of a DNA-enrichment microfluidic chip. Reprinted
with permission from Oh et al., Anal. Chem. 81, 2832 (2009). Copyright 2009 American Chemical Society. (b) Automated
microfluidic ChIP assay device. Reprinted with permission from Wu et al., Lab Chip 9, 1365 (2009). Copyright 2009
Royal Society of Chemistry. (c) High throughput automated ChIP assay platform. Reprinted with permission from Wu
et al., Lab Chip 12, 2190 (2012). Copyright 2012 Royal Society of Chemistry. (d) ChIP assay platform for histone modifi-
cation analysis of a low number of cells. Reprinted with permission from Geng et al., Lab Chip 11, 2842 (2011). Copyright
2011 Royal Society of Chemistry.
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sodium dodecyl sulfate (SDS)/ethylenediaminetetraacetic acid (EDTA) solution is used not only
to neutralize the MNase but also to break the remaining cell membrane completely. The beads
utilized in ring 1 function as a matrix to keep the cells in the gap between each beads as solu-
tions are exchanged. When the cell lysate meets antibody tagged microbeads, precipitation
occurs in ring A to D regions in which different antibody tagged microbeads are deposited
using sieve valves. During this immunoprecipitation procedure, the cell lysate and antibody
tagged microbeads are well-mixed by active pumping, resulting in reduced incubation times.
With careful washing that does not strip target proteins bound to the antibody beads, the cross-
linked DNA on the target proteins is isolated and amplified with real time qPCR. The study
precipitated two target proteins, H3K4me3 and H3Ac in parallel. Compared to the conventional
ChIP assay protocol, the ratio of acquired target molecules over total input molecules from cells
was improved. The key to improvements include increased interaction between concentrated
cell lysate and antibody in the small channel as well as the active mixing during immunopreci-
pitation. This method reduces the total operation time to less than a day, and the required cell
population to approximately 2000 cells. In contrast, conventional ChIP assays¼ require large
numbers of cells (over 1 106 cells) and longer times (up to several days; Table I). Building
on this work, the group has scaled up their platform to establish a high throughput automated
chromatin immunoprecipitation (HTChIP) platform for drug screening and antibody validation
(Fig. 4(c)).74 The HTChIP is designed to use conventional sample preparation protocols of cell
lysis and chromatin fragmentation in bulk to utilize existing infrastructures and to make the
microfluidics chip more focused on the immunoprecipitation step. The HTChIP has been used
to successfully observe changes in transcription factor binding in murine embryonic fibroblast
(MEF) under TNF-a stimulation.
Another approach for improved ChIP based histone modification analysis in a PDMS micro-
fluidic device was reported by Lu et al. In conjunction with magnetic beads, rapid immunopreci-
pitation and purification of target DNA are achieved. (Fig. 4(d)).75 Similar to the microfluidics
devices described above, fluids are controlled in the PDMS microfluidic device by pumps and
valves. Antibody conjugated magnetic beads are initially introduced by pumps and an external
magnetic force. Cells are then introduced among the magnetic beads by partially opening a valve
to allow fluid flow, creating a bead/cell capture area. The cells are ruptured with a cell lysis
buffer, and chromatin is fragmented by MNase. After neutralizing the enzyme activity, immuno-
precipitation is conducted under enhanced mixing by both periodic actuation of valves at a high
frequency, and by movement of an external magnetic field. The magnetic beads capturing the tar-
get proteins are sorted after thorough washing to flush non-specifically bound materials. Increased
interaction between the target protein in chromatin and the antibody on the magnetic beads in the
microscale chamber results in needing fewer cells and reduces operation time. Coupled with real-
time PCR, they characterized histone acetylation in immature 6C2 cells, using as few as 50 cells
to provide biologically meaningful results within a few hours.
Despite advances made in using microfluidics to improve ChIP methodologies, there is still
a need to enable detection of multiple types of histone modifications simultaneously across the
whole genome, on a single-cell level, in order to study epigenetic influences of rare cells.
Achieving this goal requires technologies that can bypass two limitations associated with the
conventional ChIP process: (1) The need for large number of cells to provide the required
amount of nuclear material; and (2) The inability to amplify chromatin. These challenges have
led to development of alternatives to ChIP to identify histone modifications directly on chroma-
tin. Some micro-nanofluidic methods to achieve this are highlighted below.
B. Chromatin linearization
Since chromatin exists in a highly compact state, specific markers in chromatin are quite
difficult to discriminate when tangled. ChIP assays include a shearing step to generate chroma-
tin fragments to overcome the entanglement problem. The harsh mechanical forces, however,
may damage epigenetic information. More importantly, extensive fragmentation of the chroma-
tin strand destroys positional information for epigenetic markers on the genomic structure. An
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alternative approach is to directly observe the position of epigenetic markers along a long
strand of chromatin. This approach requires chromatin to be linearized, a task suited to micro
and nano-fluidics. Nanochannels are well known to provide confinement conditions that allow
for reliable linearization of DNA.76–80 More recently, chromatin has also been linearized by
nanoconfinement. With fluorescent labeling using multiple antibodies against specific histone
modification, positions of epigenetic markers can then be directly imaged.81–83
To date, efforts to study DNA linearization in micro/nanofluidics have been oriented to-
ward the visualization of single DNA molecules and the detection of target markers on
DNA.84–86 In this short review, we focus on fluidic approaches that linearize chromatin where
DNA with its associated proteins is stretched intact. The first demonstration of linearizing chro-
matin in nanochannels was performed by Streng et al.87 This group fabricated nanochannels
with approximately 80 80 nm2 cross-sectional area on silica wafers. Due to the difficulty of
estimation of DNA lengths in a chromatin molecule extracted from a single cell, they reconsti-
tuted chromatin by combining unfractionated whole histones with the well characterized
k-DNA. The reconstituted chromatin was dragged into the nanochannels using an electrical field
(Fig. 5(a)). Frictional force involved with forcing the globular chromatin to stretch into the
nanochannel and entropic effects of nanoconfinement linearize the chromatin and maintain it in
that state. Stretched chromatin and DNA were visualized by staining with the intercalating dye,
YOYO-1, and lengths with and without histones were compared (Fig. 5(b)). Consequently, they
demonstrated that elongated reconstituted chromatin contained 2.5 times the number of compact
structures as compared to bare DNA in its stretched state. Considering normal diffraction-
limited optical microscopy limits, the measured length of elongated chromatin corresponds to a
chromatin mapping resolution of 6 kbp. A high throughput approach to analyze epigenetic
markers in single DNA or chromatin molecules in nanofluidics was reported by the Craighead
group.81 A few hundred nanometer sized channels, fabricated on a fused silica wafer by projec-
tion photolithography and reactive ion etching, combined with multicolor fluorescence confocal
microscopy enable detection of multiple target markers on single molecules simultaneously at a
high rate of approximately 10 Mbp/min. Here, the main purpose of the nanochannels is to space
out chromatin fragments from each other so that each fragment is analyzed one by one as they
are electrokinetically driven through nanochannels. Two lasers focused on the nanochannel
allow coincident multi-fluorescence color detection (Fig. 5(c)). For example, the group used
TOTO-3 (red color to stain DNA) and histone H2B-GFP (green) to simultaneously measure
DNA and histone content of each chromatin fragment as it passed the detection region
(Fig. 5(d)). They also successfully detected methylation of DNA and presence of histones by
use of a fluorescently tagged methyl binding domain protein-1 (MBD1). Recently, they ana-
lyzed the coincidence of three gene silencing/activating marks—H3K9me3 and H3K27me3 on
histone and cytosine methylation (mC) on DNA—in normal and cancer cells to reveal higher
incidents of “contradicting” marks (activating histone marks together with silencing DNA meth-
ylation marks) in cancer cells.88 Multi-color analysis enabled direct confirmation of the
presence or absence of multiple modifications on each chromatin fragment enabling direct con-
firmation of these markings which could only be indirectly inferred previously.
Recently, Matsuoka et al. presented multi-color histone mapping in nanochannels. In this
method, an array of nanochannels are fabricated based on cracking of a brittle PDMS surface
layer.83 The key to achieving chromatin linearization in these nanochannels is the ability to
modulate the channel cross-sectional dimensions. This channel tuneability is useful not only for
easily loading of chromatin into the channels using the channel-widened state but also for
actively linearizing the chromatin structure by the application of elongational squeezing shear
flows as the channels are narrowed (Fig. 5(e)). This chromatin linearization is gentle and quick
enough to allow anti-histone antibody-labeled chromatin to be elongated with their markings
maintained but vigorous enough to linearize to near estimated contour lengths. The elongated
chromatin was visualized by combinations of fluorescent DNA intercalating dyes, fluorescently
labeled antibodies for specific target histone modifications, or histone-GFP. Examples of multi-
color chromatin analysis demonstrated include simultaneous mapping of histone-H3K9me3,
histone-H4Ac, and DNA on the linearized chromatin (Fig. 5(f)).
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As an alternative to fluidic channels, chromatin molecules can also be linearized and
arrayed on a substrate via soft lithography and fragment immobilization. Cerf et al. recently
demonstrated this approach (Fig. 5(g)).89 Chromatin molecules are elongated on a PDMS stamp
having microfeatures and the array of linearized chromatin transferred to a functionalized cover
slip for high resolution imaging. Stretched chromatin extracted from cancerous cell lines such
as M091 and HeLa were utilized for epigenetic analysis. Target histone in the arrayed chroma-
tin was observed with fluorescence microscope and conformations of the elongated chromatin
were characterized by AFM.
To enhance our understanding of chromatin behaviour at the molecular scale in these nano-
fluidic environments, it will be critical to utilize computational simulations, since direct obser-
vation is difficult. Computational modeling of chromatin states and dynamics in confined
geometries has only just begun.83,87 There are unique challenges and opportunities for perform-
ing such analyses. In addition to the interaction with boundaries, the hydrodynamic effects and
polymer drift (such as in electrophoresis), must be properly addressed in the model. For analy-
sis of hydrodynamic effects, the CG model may also need to explicitly include a solvent which
would increase computational loads. Simple models such as the semi-flexible chain model
based on the persistence length of the polymer may not be generally reliable. The reported
FIG. 5. Chromatin linearization in micro/nanofluidic systems. (a) Schematics of reconstituted chromatin linearization in
nanochannels. (b) Linearization of chromatin assembled from lambda-DNA and bare lambda DNA in nanochannels.
Reprinted with permission from Streng et al., Lab Chip 9, 2772 (2009). Copyright 2009 Royal Society of Chemistry. (c)
Experimental platform for single chromatin analysis at the nanoscale. (d) Coincidence two color measurements of stained
DNA and GFP expressed histone on a single chromatin. Reprinted with permission from Cipriany et al., Anal. Chem. 82,
2480 (2010). Copyright 2010 American Chemical Society. (e) Chromatin elongation induced by hydrodynamic squeezing
flow as well as confinement effect as channel narrows. (f) Multi-color epigenetic marker mapping for histone-H3K9me3 or
histone-H4Ac on linearized chromatin. Reprinted with permission from Matsuoka et al., Nano Lett. 12, 6480 (2012).
Copyright 2012 American Chemical Society. (g) Individual chromatin molecules contain valuable genetic and epigenetic
information. Reprinted with permission from Cerf et al., ACS Nano 6, 7928 (2012). Copyright 2012 American Chemical
Society.
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persistence length spans a broad range from 30 nm to 300 nm,41,42 reflecting the sensitivity of
the system to the environmental variables previously discussed.
IV. SUMMARYAND FUTURE PERSPECTIVES
The ability to map the whole human genome in combination with more recent advances in
chromatin analysis based on histone modifications by the ENCODE project have provided the
basis for scientists to identify the dynamic processes involved in epigenetics. The limitations
imposed by available techniques have prompted the development of novel technologies to con-
duct a genome-wide epigenetic analysis, using very few cells while minimizing time, cost and
assay complexity. Furthermore, the ability to analyze positional relationships between multiple
histone markers simultaneously from a single chromatin molecule will enhance our mechanistic
understanding of the roles of the various markings and how it contributes to normal physiology
as well as disease. There are still relatively few micro- and nanofluidic methods that have been
developed for chromatin analysis. Micro- and nano-engineering approaches described in this
review provide a glimpse of the promising approaches developed to towards this goal.
Combined with developments in super resolution imaging techniques,90,91 the nanofluidic single
molecule-level direct chromatin analysis looks poised for further advances. We hope this review
will encourage increased participation in this important field.
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